Publications

Radiogenomics of Pancreatic Ductal AdenoCarcinoma  (2022)

Authors:
Longo, Chiara; Geraci, Luca; Tomaiuolo, Luisa; Autelitano, Daniele; Todesco, Marco; Rossi, Vittoria; Cicalò, Francesco; Verrengia, Francesco; D'Onofrio, Mirko
Title:
Radiogenomics of Pancreatic Ductal AdenoCarcinoma
Year:
2022
Type of item:
Poster
Tipologia ANVUR:
Poster
Language:
Inglese
Format:
Elettronico
Congresso:
ECR 2022 - ESR - European Society of Radiology
Place:
Austria Center Vienna, Austria
Period:
13/07/2022 – 17/07/2022
Page numbers:
1-1
Keyword:
Artificial Intelligence, Oncology, Pancreas, CT, MR, Experimental investigations, Outcomes analysis, Radiobiology, Tissue characterisation
Short description of contents:
The aim of our study was to perform a simplified radiomic analysis of pancreatic ductal adenocarcinoma based on qualitative and quantitative tumor features and to compare the results with different muted genes, in particular with KRAS and TP53 expression, in order to predict the outcome and, in future, to direct the therapeutic path.
Note:
Pancreatic cancer has a very poor prognosis and its most frequent isotype is represented by pancreatic ductal adenocarcinoma (PDAC). Despite advances in early diagnosis and multimodal treatments, the prognosis for patients with PDAC remains poor, with a 5-year survival rate that lies around 8%. According to genomics, there are certain genes often mutated in PDAC’s carcinogenesis: KRAS, CDKN2a/INK4a, TP53, and DPC4/SMAD4. In particular we focused on the presence or absence of KRAS mutation as it is the most frequent mutated oncogene (95%) that determine an increased growth and survival of tumoral cells. Secondly we analyzed TP53 expression as it is demonstrated that it is inactivated in up to 75% of the PDAC. The aim of our study was to perform a simplified radiomic analysis of pancreatic ductal adenocarcinoma based on qualitative and quantitative tumor features and to compare the results with different muted genes, in particular with KRAS and TP53 expression, in order to predict the outcome and, in future, to direct the therapeutic path. At our knowledge, this is the first study that looks for radiogenomic data for PDAC through RM imaging.
Web page:
https://dx.doi.org/10.26044/ecr2022/C-14768
Product ID:
132157
Handle IRIS:
11562/1075328
Last Modified:
February 23, 2023
Bibliographic citation:
Longo, Chiara; Geraci, Luca; Tomaiuolo, Luisa; Autelitano, Daniele; Todesco, Marco; Rossi, Vittoria; Cicalò, Francesco; Verrengia, Francesco; D'Onofrio, Mirko, Radiogenomics of Pancreatic Ductal AdenoCarcinoma  in EPOSProceedings of "ECR 2022 - ESR - European Society of Radiology" , Austria Center Vienna, Austria , 13/07/2022 – 17/07/2022 , 2022pp. 1-1

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo IRIS

<<back

Activities

Research facilities

Share